Selected drugs, therapeutic alternatives, and price benchmarks for IPAY 2027 Medicare drug price negotiation.

Sullivan SD, Cousin EM, Li KH, Gabriel N, Martin K

Open source

DOI
10.18553/jmcp.2025.25199
Published
2025 Oct
Container
Journal of managed care & specialty pharmacy
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.18553/jmcp.2025.25199,
  title = {Selected drugs, therapeutic alternatives, and price benchmarks for IPAY 2027 Medicare drug price negotiation.},
  author = {Sullivan SD and Cousin EM and Li KH and Gabriel N and Martin K},
  year = {2025},
  journal = {Journal of managed care \& specialty pharmacy},
  doi = {10.18553/jmcp.2025.25199},
  url = {https://doi.org/10.18553/jmcp.2025.25199}
}

RIS

TY  - JOUR
TI  - Selected drugs, therapeutic alternatives, and price benchmarks for IPAY 2027 Medicare drug price negotiation.
AU  - Sullivan SD
AU  - Cousin EM
AU  - Li KH
AU  - Gabriel N
AU  - Martin K
PY  - 2025
JO  - Journal of managed care & specialty pharmacy
DO  - 10.18553/jmcp.2025.25199
UR  - https://doi.org/10.18553/jmcp.2025.25199
ER  - 

APA

SD, S., EM, C., KH, L., N, G., & K, M. (2025). Selected drugs, therapeutic alternatives, and price benchmarks for IPAY 2027 Medicare drug price negotiation.. Journal of managed care & specialty pharmacy. https://doi.org/10.18553/jmcp.2025.25199

Source records